Home authorization
 

Keywords :   


Tag: authorization

Fonon Corporation (Formerly Mabwe Minerals Inc.) Receives Clearance from FINRA Including Authorization for 10:1 stock split and Issued New Ticker Symbol: FNON

2015-09-09 12:31:09| Industrial Newsroom - All News for Today

Mabwe Minerals is now Fonon Corporation, completes Phase I of company's 2015 Reorganization Plan with FINRA approval of name change, domicile change, stock split and new ticker symbol Lake Mary, Florida, - Fonon Corporation (formerly Mabwe Minerals) (OTC: FNON) is pleased to announce the company has successfully...

Tags: new including stock corporation

 

Veteran Affairs Request and Authorization to Release HMIS Information

2015-09-04 22:08:59| PortlandOnline

ServicePoint Users only, Please transact ROI as trained and return completed form to PHB Questions? Contact Wendy Smith or Hunter Belgard PDF Document, 385kbCategory: Multnomah County Resources

Tags: information request release affairs

 
 

Environmental Services Company Expands Capabilities with New Authorization to Transport Ebola Suspected or Confirmed Medical Waste

2015-08-07 12:31:18| Industrial Newsroom - All News for Today

SWS Environmental Services recently acquired a new operating permit from the United States Department of Transportation. Panama City Beach, FL SWS Environmental Services (SWSES) has been granted "Party Status" by the United States Department of Transportation (USDOT), Pipeline and Hazardous Materials Safety...

Tags: services company medical transport

 

Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test

2015-08-03 19:27:07| Biotech - Topix.net

OraSure Technologies, Inc. , a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administration Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test for use with fingerstick and venous whole blood. This test has not been cleared or approved by FDA.

Tags: test technologies rapid emergency

 

Merck Announces European Medicines Agency Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection

2015-07-23 17:02:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1, 3, 4 or 6 infection.1 The EMA will initiate review of the MAA under accelerated assessment timelines. Language: English Contact: Merck & Co., Inc.Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of application marketing treatment

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »